Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOakley Regulatory News (OCI)

Share Price Information for Oakley (OCI)

Share Price is delayed by 15 minutes
Get Live Data
522.00    2.00 (0.38%)
Bid:
518.00
Ask:
522.00
Spread: 4.00 (0.772%)
Market Cap: £863.73m
OCI Live PriceLast checked at - London Stock Exchange

Intraday Oakley Share Chart

Update from QuotedData

20 Dec 2023 09:39

RNS Number : 4677X
Oakley Capital Investments Limited
20 December 2023
 

 

Oakley Capital Investments - Update from QuotedData

20th December 2023

Walking the walk

Despite broader economic challenges, Oakley Capital Investments (OCI) continues to deliver outstanding, market beating shareholder returns. Its focus on cash-generative companies with recurring revenues and asset-light business models means the portfolio remains well insulated as financial conditions have tightened, highlighted by double digit earnings growth over the last financial year. The staggered nature of its investments has provided a consistent stream of realisations (at an average premium of 35%), validating net asset values (NAVs) and providing plenty of financial flexibility.

The latest of these was the £240m sale of its stake in IU group, which crystalised an 85% IRR. Despite this execution and market leading track record, shares remain at a considerable discount to NAV. While this reflects broader market weakness across unlisted assets, it is difficult to see how it can be justified over the long term given the strength of the company's NAV growth.

Full Research:

https://quoteddata.com/research/oakley-capital-investments-walking-walk-qd/

This research is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

NB: Marten & Co was paid to produce this note on Oakley Capital Investments and it is for information purposes only. It is not intended to encourage the reader to deal in the security or securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading name of Marten & Co Limited which is authorised and regulated by the Financial Conduct Authority. Marten & Co is not permitted to provide investment advice to individual investors categorised as Retail Clients under the rules of the Financial Conduct Authority.

QUOTEDDATA50 Gresham Street | London EC2V 7AYTel: +44 (0) 20 3691 9430

www.quoteddata.com | research@quoteddata.com | www.martenandco.com

 

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAUROKROWUUURA
Date   Source Headline
10th Nov 20224:15 pmRNSDirector/PDMR Shareholding
26th Oct 20227:00 amRNSTrading update for the 3 months ended 30 Sep 2022
13th Oct 20227:00 amRNSOakley Capital agrees partial exit from Wishcard
10th Oct 202211:55 amEQSHardman & Co Research : Q&A on Oakley Capital Investments (OCI) | 1H'22 results once again proving NAV is real and resilient
30th Sep 20223:00 pmRNSResult of AGM
20th Sep 20224:00 pmEQSHardman & Co Research on Oakley Capital Investments Ltd (OCI): 1H’22: results prove NAV real, resilient and growing
8th Sep 20227:00 amRNSInterim results for the 6 months ended 30 June 22
6th Sep 20227:00 amRNSOakley agrees follow-on investment in Facile.it
5th Sep 202212:26 pmRNSOakley Capital invests in vLex
5th Sep 20227:05 amRNSNotice of Annual General Meeting
30th Aug 202212:00 pmRNSOakley Capital invests in Phenna Group & CTS Group
26th Aug 20227:00 amRNSNotice of Results and Investor Presentation
25th Aug 20227:00 amRNSOakley Capital invests in Affinitas Education
8th Aug 20227:00 amRNSTransaction in Own Shares
27th Jul 202210:00 amRNSOakley Capital agrees partial exit from Seedtag
27th Jul 20227:00 amRNSTrading update for the 3 months ended 30 June 2022
26th Jul 20222:00 pmRNSOakley's Grupo Primavera to merge with Cegid
29th Jun 202212:50 pmRNSDirector Dealing
29th Jun 20227:00 amRNSTransaction in Own Shares
28th Jun 20227:00 amRNSTransaction in Own Shares
23rd Jun 20227:00 amRNSOakley Capital agrees sale of Facile.it
10th Jun 202211:05 amEQSHardman & Co Research: Q&A on Oakley Capital Investments: Impressive market and peer-beating 19% NAV CAGR growth 2017-21
8th Jun 20227:00 amRNSSale of Contabo and follow-on investment
16th May 20222:15 pmEQSHardman & Co Research: Oakley Capital Investments (OCI) - Capital Markets Day 2022 – let the sun shine
10th May 20227:00 amRNSDirector Dealing
9th May 20227:00 amRNSTransaction in Own Shares
6th May 20227:00 amRNSInvestment in Vice Golf
5th May 20227:00 amRNSTransaction in Own Shares
4th May 20227:00 amRNSTransaction in Own Shares
3rd May 20227:00 amRNSTransaction in Own Shares
27th Apr 20227:00 amRNSTrading update for the 3 months ended 31 March 22
19th Apr 20225:00 pmEQSHardman & Co: Q&A on Oakley Capital Investments Ltd: Proving the pudding: a sustainable growth model'
8th Apr 20221:38 pmRNSHolding(s) in Company
28th Mar 20227:00 amRNSTransaction in Own Shares
16th Mar 20222:45 pmEQSHardman & Co Research: Oakley Capital Investments Ltd (OCI) - Proving the pudding: a sustainable growth model
14th Mar 20223:04 pmRNSDirector Dealing
11th Mar 20226:17 pmRNSDirector Dealing
11th Mar 20229:08 amRNSResults analysis from Kepler Trust Intelligence
10th Mar 20227:04 amRNSShare Buy-Back Programme
10th Mar 20227:00 amRNSFinal Results for the year ended 31 December 2021
3rd Mar 20227:00 amRNSNotice of Results and Webcast Presentation
9th Feb 20228:30 amEQSHardman & Co Research: Oakley Capital Investments (OCI) Educating on education
31st Jan 202212:52 pmRNSDirector Dealing
31st Jan 202212:51 pmRNSDirector Dealing
28th Jan 20222:05 pmRNSDirector Dealing
27th Jan 20221:40 pmRNSFlash update from Kepler Trust Intelligence
26th Jan 20227:00 amRNSTrading Update for the Year Ended 31 December 2021
21st Dec 20217:00 amRNSNew Investment Advisory Agreement
17th Dec 20213:41 pmRNSHolding(s) in Company
16th Dec 20211:05 pmEQSHardman & Co Video : Hardman Talks | Everything you wanted to know about private equity but were afraid to ask!

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.